Overview

Dr. Orlando is a clinician-scientist focusing on multiple sclerosis (MS) and related disorders. His research examines the relationship of social determinants of health with MS care and outcomes, including the ways inequities give rise to health health disparities. Current projects include investigations of the causes of delayed diagnosis of MS and how these may differ among demographic groups.

Awards

  • National MS Society: Sylvia Lawry Physician Fellowship, 2023
     – 2025
  • Race to Erase MS Foundation: Young Investigator Award, 2025
     – 2027
  • SC CTSI / NIH NCATS: KL2 / Mentored Career Development in Clinical and Translational Science, 2026
     – 2029

Education and Training

  • University of Utah School of Medicine, Salt Lake City, UT — MD — 05/2019
  • University of Utah School of Medicine, Salt Lake City, UT — MPH — 05/2019
  • University of Texas Health Science Center at Houston, Houston, TX — 06/2023 — Neurology
  • Keck School of Medicine of USC, Los Angeles, CA — 06/2025 — MS/Neuroimmunology
  • Keck School of Medicine of USC, Los Angeles, CA — graduate certificate — 05/2025 — Clinical Translational Research

Research Funding

  • Identifying Intervenable Factors Related to Delayed Diagnosis of Multiple Sclerosis
    National Institutes of Health · Apr 1, 2026 – Mar 31, 2029 · Role: KL2 Scholar in Mentored Career Development in Clinical Translational Science (MCD-CTS) Program
  • Factors Associated with Delayed Diagnosis and Treatment of Multiple Sclerosis
    Race to Erase MS · Jan 1, 2026 – Dec 30, 2026 · Role: principal invesitgator
  • Research Training for Neurosurgery and Neurology Residents & Fellows
    NIH · R25NS113757 · Jul 1, 2020 – Jun 30, 2025 · Role: Co-Investigator

Research Keywords

  • multiple sclerosis
  • neuroimmunology
  • social determinants of health
  • health equity
  • health disparities
  • healthcare access

Publications

  • Alliance for research in hispanic multiple sclerosis registry as a facilitator to clinical research participation. Mult Scler Relat Disord. 2026 Jun; 110:107188.. View in PubMed
  • Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis. Ann Clin Transl Neurol. 2025 03; 12(3):615-630.. View in PubMed
  • Person-Centered Social Determinants and Neighborhood-Level Deprivation Associated With Disability in Hispanic People With Multiple Sclerosis. Neurology. 2025 Feb 11; 104(3):e213332.. View in PubMed
  • A tale of race and B cells in multiple sclerosis. Nat Rev Neurol. 2024 01; 20(1):5-6.. View in PubMed
  • Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved. Neurol Clin. 2024 Feb; 42(1):295-317.. View in PubMed
  • Social determinants of health and disparate disability accumulation in a cohort of Black, Hispanic, and White patients with multiple sclerosis. Mult Scler. 2023 09; 29(10):1304-1315.. View in PubMed